Otonomy to Report Third Quarter 2020 Financial Results and Provide Corporate Update
October 28 2020 - 7:30AM
Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company
dedicated to the development of innovative therapeutics for
neurotology, today announced it will report financial results for
the third quarter of 2020 and provide a corporate update at 4:30
p.m. ET on November 4, 2020.
The live call may be accessed by dialing (877)
305-6769 for domestic callers and (678) 562-4239 for international
callers with conference ID code number: 5179918. A live webcast of
the call will be available online in the investor relations section
of Otonomy’s website at www.otonomy.com and will be archived there
for 30 days.
About OtonomyOtonomy is a
biopharmaceutical company dedicated to the development of
innovative therapeutics for neurotology. The company pioneered the
application of drug delivery technology to the ear in order to
develop products that achieve sustained drug exposure from a single
local administration. This approach is covered by a broad patent
estate and is being utilized to develop a pipeline of products
addressing important unmet medical needs including Ménière’s
disease, hearing loss, and tinnitus. For additional information
please visit www.otonomy.com.
Contacts:
Media Inquiries:Spectrum ScienceChloé-Anne
RamseyVice President404.865.3601cramsey@spectrumscience.com
Investor Inquiries:Westwicke ICRRobert H.
UhlManaging Director858.356.5932robert.uhl@westwicke.com
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Oct 2024 to Nov 2024
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Nov 2023 to Nov 2024
